Status
What we claim,
and on what basis.
Every technology on this site carries a status label. This page defines those labels.
Status definitions
- OPERATING
A company delivering services to customers today.
Applies to: Heros Health, Telecheck Health
- IN DEVELOPMENT
Active engineering work toward availability.
Applies to: ONE-C, ONE-R, FLEXOR Sock System, AESS, In-Flight Companion
- RESEARCH
Investigation stage: a question under study, with instrumentation built to study it.
Applies to: DFPAS platform, Remote Neuromuscular Stimulation Suite
- FORWARD-LOOKING DESIGN
Designed on paper; built as prior stages complete.
Applies to: ONE-CL, the Adapt stage of the DFPAS loop
- CONCEPTUAL EXPLORATION
Idea stage, published because the direction is real.
Applies to: ONE-0G and all microgravity work
Regulatory path
DFPAS is planned to launch first under the FDA General Wellness category, a category defined by FDA enforcement discretion. Clinical studies are planned: performance verification (n=30), then a larger stage (n=200).
This site describes research and technology programs. Care decisions belong with a clinician.
Patent status
The first patent in the portfolio has been allowed by the USPTO. Additional applications are advancing through examination. Patent numbers, claims, and titles are published here upon issuance.
The portfolio is held by Arthur Menson Labs.
The group
First Empire Holdings LLC is the holding company. Heros Health and Telecheck Health are its operating companies. Arthur Menson Labs is the group’s nonprofit research institute, directed by First Empire through governance.
Attribution standard
First Empire publishes transaction records when they are attributable and verifiable. Credentials of the individuals who advise First Empire reflect their own firms and ventures.
Forward-looking statements
Statements on this site about planned variants, intended launches, research directions, and future applications describe intention under present understanding. Outcomes follow technical results, regulatory outcomes, and capital.
If anything on this site is inaccurate, we would like to know and we will correct it.
Contact us